Navigation Links
Genomic Health Announces Third Quarter 2011 Financial Results and Business Progress
Date:11/1/2011

test in over 1,800 patients with node-negative breast cancer and described a wide range of Recurrence Score® biology across patient age, tumor size, and tumor grade. These results, presented at the ASCO Breast Cancer Symposium in September, reconfirmed that the underlying biology revealed by the Recurrence Score result could not be predicted from the traditional clinical and pathologic factors.
  • The Journal of Clinical Oncology published results of a meta-analysis of 1,735 patients from the landmark NSABP B-14 and ATAC breast cancer trials that demonstrated combining the Oncotype DX breast cancer Recurrence Score with traditional pathology and clinical measures (RSPC) can supplement the assessment of recurrence risk.  
  • The Journal of Clinical Oncology published results from the NSABP B-14 study of patients randomized to surgery alone, that demonstrated the value of the Oncotype DX quantitative estrogen receptor (ER) result as a predictor of tamoxifen benefit.
  • On track to finalize  prostate cancer assay parameters and algorithm with the goal of initiating a large clinical validation study in 2012.

  • Conference Call Details To access the live conference call today, November 1 at 4:30 p.m. Eastern Time via phone, please dial (877) 303-7208 from the United States and Canada or +1(224) 357-2389 internationally.  Please dial in approximately ten minutes prior to the start of the call.  A telephone replay will be available beginning approximately two hours after the call through November 8, and may be accessed by dialing (855) 859-2056 from the United States and Canada or +1(404) 537-3406 internationally. The replay passcode is 19902340.

    To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company's website at http://investor.genomichealth.com/events.cfm'/>"/>

    SOURCE Genomic Health, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    3. Personalized Medicine - The Genomic Revolution in Cardiac Care
    4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
    5. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
    6. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
    7. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
    8. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
    9. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
    10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
    11. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/27/2015)... WASHINGTON , May 27, 2015 Doctors ... Innovation at Children,s National Health System ... to treat osteoid osteoma, a benign but ... young adults, using an experimental magnetic resonance-guided high-intensity focused ... and 10-year-old Niyati Shah , have been ...
    (Date:5/27/2015)... 25, 2015 Research and Markets ... of the "2015 Strategies in the European ... This comprehensive five-country report contains 500 ... current suppliers and potential market entrants identify and ... testing market during the next five years. ...
    (Date:5/27/2015)... DUBLIN , May 25, 2015 Research ... the "Global Rapid Medical Diagnostic Kits Market - ... Global market for Rapid Medical Diagnostic Kits, estimated ... in 2015 and further expected to maintain a CAGR ... projected US$27 billion by 2020. The global ...
    Breaking Medicine Technology:Children's National first in US to destroy bone tumors with incisionless surgery 2Children's National first in US to destroy bone tumors with incisionless surgery 3Children's National first in US to destroy bone tumors with incisionless surgery 4European Coagulation Testing Market Strategies 2015 2Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 2Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 3Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 4
    ... sleep onset, sleep maintenance ... total sleep time compared to placebo, BRIDGEWATER, N.J., June ... showed Ambien CR(R) (zolpidem,tartrate extended-release) CIV tablets 12.5 mg provided ... over 8,weeks in patients with co-morbid insomnia and major depressive ...
    ... of Roche and Ipsen,s First Once-Weekly Human ... Meeting -, NUTLEY, N.J., June 10 Roche ... been shown to provide,significant improvements in glucose control and ... safety and tolerability profile that,supports entry into Phase III. ...
    Cached Medicine Technology:Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 2Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 3Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 4Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 2Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 3Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 4Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 6
    (Date:5/27/2015)... Black Book Rankings, well known ... the multiple services and software industries, conducted a ... ranked Electronic Health and Medical Record software systems ... focus on implemented EHR users, Black Book reveals ... the highest scores in client experience among small ...
    (Date:5/27/2015)... Texas (PRWEB) May 27, 2015 The ... of three FDA-approved dermal filler treatments in Abilene, Texas: ... to reduce the appearance of glabellar lines, better known ... Belotero Balance® is designed to treat smoker’s lines ... to the chin, while Radiesse® improves the appearance of ...
    (Date:5/27/2015)... Coco Libre announced today that artists and audiences ... Organic Coconut Water to quench their thirst during the festival ... areas, artist greenrooms, corporate skyboxes and concessions areas at the ... on festival shuttle buses. , “We’re excited to have ... Director of Strategic Partnerships for Latitude 38 Entertainment, producer of ...
    (Date:5/27/2015)... Arizona (PRWEB) May 27, 2015 Genius ... of their advanced programmatic marketing technology, they have boosted ... advertising support on a regional level for seven Utah-based ... marketing was through television and radio media. In 2014 ... with the help of Genius Monkey , shifted ...
    (Date:5/27/2015)... Iowa (PRWEB) May 27, 2015 With ... away, a poll conducted during the "ACA - Controlling ... poll participants, 75% are currently in the process of ... over 15% were confidently prepared for the reporting mandates. ... shown during the webinar, those who are currently vetting ...
    Breaking Medicine News(10 mins):Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2
    ... Archives of Internal Medicine says that drinking two cups of ... 46 percent. // ,Researchers from the Karolinska ... of 40 and 76 during 1987 to 2004. They found ... this time. When the study started two-thirds of the participants ...
    ... good sleep help elderly women maintain a destructive protein ... is connected to health problems like Alzheimer's, heart disease, ... Interleukin-6 (IL-6) which runs in the blood stream rises ... damaging protein sank in women who managed to sleep ...
    ... and amoxicillin when it comes to treating ailments like ... effective. Doctors, who reviewed the treatment given to // ... the newer drugs is more effective than the traditional ... ,Pediatricians at the University of Rochester Medical Center found ...
    ... studied the blood pressure (BP) and eating habits of 4,304 people ... 18 years and 30 years. An inverse connection was // seen ... grain, and milk, when in comparison to low plant food intake. ... and 36% by the consumption of the second and fifth quintiles. ...
    ... Canada has announced a ban on the anti-inflammatory drug Bextra, ... from the drug were outweighed by the cardiovascular risks, including ... to an expert safety panel. ,The drug ... even prove to be fatal. Pfizer had earlier withdrawn the ...
    ... is under threat from a drinking problem. This result is ... for Addictions Research of B.C. compared drinking patterns of the ... on the Canadian Addiction Survey done in 2004. ,The ... guidelines for alcohol consumption and 53 per cent were above ...
    Cached Medicine News:Health News:Penicillin To Pave Way For New Antibiotics 2
    ... The Zeus Scientific, Inc. ENA Profile-6 ... for the detection of IgG antibodies to ... in human sera. When performed according to ... autoantibody profile may aid in the diagnosis ...
    Inquire...
    ... Microalbumin Urine Controls are supplied ... liquid requiring no reconstitution or ... human urine, fortified to target ... creatinine. Preservatives including sodium azide ...
    The K-ASSAY ITA Lyophilized Multi-Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assays for the li...
    Medicine Products: